532 related articles for article (PubMed ID: 31470672)
1. Cellular and Synaptic Dysfunctions in Parkinson's Disease: Stepping out of the Striatum.
Mallet N; Delgado L; Chazalon M; Miguelez C; Baufreton J
Cells; 2019 Aug; 8(9):. PubMed ID: 31470672
[TBL] [Abstract][Full Text] [Related]
2. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.
Cobb WS; Abercrombie ED
Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit.
Tozzi A; Sciaccaluga M; Loffredo V; Megaro A; Ledonne A; Cardinale A; Federici M; Bellingacci L; Paciotti S; Ferrari E; La Rocca A; Martini A; Mercuri NB; Gardoni F; Picconi B; Ghiglieri V; De Leonibus E; Calabresi P
Brain; 2021 Dec; 144(11):3477-3491. PubMed ID: 34297092
[TBL] [Abstract][Full Text] [Related]
4. Substantia nigra control of basal ganglia nuclei.
Guatteo E; Cucchiaroni ML; Mercuri NB
J Neural Transm Suppl; 2009; (73):91-101. PubMed ID: 20411770
[TBL] [Abstract][Full Text] [Related]
5. Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine?
Villalba RM; Smith Y
Neuroscience; 2013 Oct; 251():2-20. PubMed ID: 23867772
[TBL] [Abstract][Full Text] [Related]
6. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
Duda J; Pötschke C; Liss B
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
8. Differential calcium channel-mediated dopaminergic modulation in the subthalamonigral synapse.
Robles-Gómez AA; Vega AV; Florán B; Barral J
Synapse; 2020 Jul; 74(7):e22149. PubMed ID: 31975491
[TBL] [Abstract][Full Text] [Related]
9. Anatomy of the dopamine system in the basal ganglia.
Smith Y; Kieval JZ
Trends Neurosci; 2000 Oct; 23(10 Suppl):S28-33. PubMed ID: 11052217
[TBL] [Abstract][Full Text] [Related]
10. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
[TBL] [Abstract][Full Text] [Related]
11. Sox6 expression distinguishes dorsally and ventrally biased dopamine neurons in the substantia nigra with distinctive properties and embryonic origins.
Pereira Luppi M; Azcorra M; Caronia-Brown G; Poulin JF; Gaertner Z; Gatica S; Moreno-Ramos OA; Nouri N; Dubois M; Ma YC; Ramakrishnan C; Fenno L; Kim YS; Deisseroth K; Cicchetti F; Dombeck DA; Awatramani R
Cell Rep; 2021 Nov; 37(6):109975. PubMed ID: 34758317
[TBL] [Abstract][Full Text] [Related]
12. Using a novel PV-Cre rat model to characterize pallidonigral cells and their terminations.
Oh YM; Karube F; Takahashi S; Kobayashi K; Takada M; Uchigashima M; Watanabe M; Nishizawa K; Kobayashi K; Fujiyama F
Brain Struct Funct; 2017 Jul; 222(5):2359-2378. PubMed ID: 27995326
[TBL] [Abstract][Full Text] [Related]
13. Synaptic dysfunction in Parkinson's disease.
Picconi B; Piccoli G; Calabresi P
Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
[TBL] [Abstract][Full Text] [Related]
14. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
[TBL] [Abstract][Full Text] [Related]
15. Synaptic and cellular plasticity in Parkinson's disease.
Chu HY
Acta Pharmacol Sin; 2020 Apr; 41(4):447-452. PubMed ID: 32112041
[TBL] [Abstract][Full Text] [Related]
16. Decreased pallidal vesicular monoamine transporter type 2 availability in Parkinson's disease: The contribution of the nigropallidal pathway.
Cho SS; Christopher L; Koshimori Y; Li C; Lang AE; Houle S; Strafella AP
Neurobiol Dis; 2019 Apr; 124():176-182. PubMed ID: 30471418
[TBL] [Abstract][Full Text] [Related]
17. Substantia nigra compacta neurons that innervate the reticular thalamic nucleus in the rat also project to striatum or globus pallidus: implications for abnormal motor behavior.
Anaya-Martinez V; Martinez-Marcos A; Martinez-Fong D; Aceves J; Erlij D
Neuroscience; 2006 Dec; 143(2):477-86. PubMed ID: 17008017
[TBL] [Abstract][Full Text] [Related]
18. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
[TBL] [Abstract][Full Text] [Related]
19. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
[TBL] [Abstract][Full Text] [Related]
20. The role of alpha-synuclein in the development of the dopaminergic neurons in the substantia nigra and ventral tegmental area.
Tarasova TV; Lytkina OA; Roman AY; Bachurin SO; Ustyugov AA
Dokl Biol Sci; 2016; 466():5-7. PubMed ID: 27021360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]